Mikuni I
Tokai J Exp Clin Med. 1980 Oct;5(4):375-84.
An anti-allergic agent (disodium cromoglycate; DSCG) was instilled in the conjunctiva of patients with Japanese cedar pollinosis during the quiescent period and, 5 minutes later, a provocation test was administered to the same patients. The extent of improvement of both subjective and objective symptoms and changes in the refractory indices of the tear samples were observed sequentially. Utilizing this method, q quantitative determination of therapeutic efficacy of the anti-allergic agent was attempted. 1. It was confirmed that DSCG improves the allergic responses, i.e., subjective and objective symptoms and the refractory indices of tears, within 5 to 10 minutes after its instillation. 2. It was established that the therapeutic efficacy of DSCG can be judged by the allergic response expressed by the refractory indices of the tear samples. 3. The quantity of the tear sample collected from individuals differs. Difficulties in collecting a sufficient quantity and the time required in the collection procedure present a technical problem in determination of refractory indices. Future improvement in the procedure is expected.
在日本雪松花粉症患者的静止期,将一种抗过敏剂(色甘酸钠;DSCG)滴入结膜,5分钟后,对同一患者进行激发试验。依次观察主观和客观症状的改善程度以及泪液样本的反应性指标变化。利用该方法尝试对抗过敏剂的治疗效果进行定量测定。1. 证实DSCG在滴入后5至10分钟内可改善过敏反应,即主观和客观症状以及泪液的反应性指标。2. 确定DSCG的治疗效果可通过泪液样本反应性指标所表达的过敏反应来判断。3. 从个体采集的泪液样本量不同。在采集足够量样本时存在困难以及采集过程所需时间在反应性指标测定中构成了一个技术问题。预计未来该程序会有所改进。